In 2020 the Legislature established the Total Cost of Insulin Work Group (Work Group) to review and design strategies to reduce the cost of—and total expenditures on—insulin in the state. The Work Group consists of the insurance commissioner and a representative appointed by the Governor from each of the following organizations:
The Work Group was required to submit a preliminary report to the Governor and Legislature by December 1, 2020, and to submit a final report to the Governor and Legislature by July 1, 2021. The Work Group expires on December 1, 2022.
On July 1, 2021, the HCA submitted a report to the Legislature stating that the Work Group was unable to convene before funding for the Work Group lapsed on June 30, 2021.
The Total Cost of Insulin Work Group (Work Group) must submit a preliminary report detailing strategies to reduce the cost of insulin by December 1, 2022. The Work Group must submit the final report to the Governor and Legislature by July 1, 2023. The Work Group expires on December 1, 2024.
If funding for the Work Group is not provided by June 30, 2022, this act is null and void.